CD7 and T-cell leukemia: In a BE trial initiated at Great Ormond Street Hospital (UCL, London), Qasim et al. generated “off-the-shelf” CAR-T cells to treat relapsed and refractory CD7+ T-cell leukemia in pediatric patients.